| HOME >> BIOLOGY >> TECHNOLOGY |
other income
(expenses) (141,491) 196,626 (95,141) 260,650
Income before income
taxes and minority
interest 6,490,503 4,791,289 9,507,830 6,219,530
Income taxes recovery
(expense)
- Current (2,579,104) (765,725) (3,224,439) (1,055,944)
- Deferred 970,614 (66,336) 897,433 (118,071)
Income before minority
interest 4,882,013 3,959,228 7,180,824 5,045,515
Minority interest
share of earnings 1,545,764 1,268,621 2,284,619 1,578,536
Net income 3,336,249 2,690,607 4,896,205 3,466,979
Other comprehensive
income
Foreign currency
translation adjustment 956,180 155,503 2,243,204 289,632
Comprehensive income $4,292,429 $2,975,174 $7,139,409 $3,931,136
Earnings per share
- basic $0.08 $0.07 $0.12 $0.09
- diluted $0.08 $0.07 $0.12 $0.09
Weighted average
number of shares
of common stock
outstanding
- Basic 42,851,228 38,745,171 41,983,709 38,734,577
- Diluted 43,210,296 39,046,811 42,351,756 39,012,980
SINOVAC BIOTECH LTD.
Consolidated Balance Sheets
(Unaudited)
(Expressed in U.S. Dollars)
June 30, 2008 December 31, 2007
ASSETS
Current assets
Cash and cash equivalents $ 18,820,271 $ 17,071,497
Accounts receivable - net 29,931,302 16,983,892
Inventories 6,369,339 3,745,957
Prepaid expense
'/>"/>
| SOURCE Sinovac Biotech Ltd. Copyright©2008 PR Newswire. All rights reserved |